Texas Attorney General Sues Tylenol Makers Over Autism Assertions

The top legal official in Texas Paxton is suing the makers of Tylenol, asserting the firms concealed alleged dangers that the medication created to pediatric neurological development.

This legal action arrives four weeks after Former President Trump publicized an unverified association between taking acetaminophen - also known as acetaminophen - throughout gestation and autism spectrum disorder in young ones.

Paxton is filing suit against the pharmaceutical giant, which formerly manufactured the medication, the only pain reliever recommended for pregnant women, and Kenvue, which presently makes it.

In a declaration, he claimed they "misled consumers by profiting off of suffering and marketing drugs regardless of the risks."

The company says there is lacking scientific proof linking acetaminophen to autism spectrum disorder.

"These corporations misled for generations, intentionally threatening millions to line their pockets," Paxton, a Republican, said.

The company commented that it was "deeply concerned by the perpetuation of misinformation on the safety of acetaminophen and the possible consequences that could have on the health of women and children in America."

On its online platform, the company also mentioned it had "continuously evaluated the applicable studies and there is insufficient valid information that demonstrates a established connection between using acetaminophen and autism."

Associations acting on behalf of medical professionals and healthcare providers agree.

ACOG has declared acetaminophen - the key substance in acetaminophen - is among limited choices for women during pregnancy to address pain and elevated temperature, which can present serious health risks if left untreated.

"In over twenty years of investigation on the use of acetaminophen in gestation, zero credible investigations has conclusively proven that the consumption of acetaminophen in any trimester of pregnancy causes brain development issues in offspring," the group said.

The lawsuit mentions current declarations from the Trump administration in claiming the drug is allegedly unsafe.

Last month, the former president generated worry from medical authorities when he advised expectant mothers to "resist strongly" not to consume Tylenol when ill.

Federal regulators then issued a notice that doctors should contemplate reducing the use of acetaminophen, while also stating that "a proven link" between the drug and autism in young ones has remains unverified.

Health Secretary Kennedy, who oversees the FDA, had pledged in April to initiate "extensive scientific investigation" that would identify the cause of autism spectrum disorder in a short period.

But authorities advised that finding a unique factor of autism spectrum disorder - believed by scientists to be the consequence of a intricate combination of inherited and surrounding conditions - would not be simple.

Autism is a type of permanent neurological difference and impairment that affects how persons experience and engage with the environment, and is identified using physician assessments.

In his court filing, Paxton - aligned with the former president who is seeking federal office - asserts the manufacturer and J&J "deliberately disregarded and attempted to silence the research" around paracetamol and autism spectrum disorder.

The lawsuit seeks to make the companies "destroy any promotional materials" that asserts Tylenol is secure for expectant mothers.

This legal action mirrors the grievances of a group of guardians of minors with autism spectrum disorder and ADHD who filed suit against the manufacturers of acetaminophen in 2022.

Judicial authorities threw out the case, declaring studies from the parents' expert witnesses was inconclusive.